Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LexaGene is covered. The 3% royalty on the machine sales is tiny.
They have recently applied for 3 additional patents to ensure they are well protected.
As far as selling the company. They won't sell off part of the company. That would devalue the companies worth and Jack wouldn't do that.
Several of the companies management have been involved in previous startup's and buyouts. They know what they are doing.
All beta users have rave reviews. The design is nearly firm.
Just try to imagine how many cartridges they will sell when the machine gets widely adopted. Their various target markets are in the tens of billions.
This is, IMHO, a tremendous opportunity.
LexaGene owns the 2 original patents. Jack is the author.
Biotechs of this nature typically sell between $300M and $800M. Would like to see the upper end.
You are correct about the one time use cartridges being like the razor blade and high margin. They will make a ton on the sale of those. They have a lease to buy program for the LX2 that will make it easy for anyone to afford to own one. That will be a big assist for sales too.
Posted on Yahoo Finance:
LexaGene Holdings Announces Filing of Final Prospectus
The Securities Commission has approved their Prospectus for financing.
This is good news. LexaGene's amazing and unique technology for pathogen testing results in one hour is revolutionary and needed worldwide. Anyone who observes what the LX2 can do wants to own it. IMO the stock is severely undervalued and undiscovered. Investors IMO who get in now at such a low stock price stand the chance of seeing their investment grow dramatically. They own the patents and have applied for more. It is my belief many millionaires will be made when it is bought out. I own shares. To see what their unique capabilities are just go to their website and read their Corp Presentation. Their broad spectrum of testing abilities and open system can't be matched. The safety of food, water, air, pets, cannabis, etc, etc can be determined in an hour.
Yes, I post all the major news releases on here. LexaGene is a diamond just waiting to be discovered. They are obtaining more financing now and they should post good news this week. LexaGene's amazing technology covers so many areas and will be in demand all over the world. It is incredible and I believe this will make many millionaires when it gets bought out.
CDX Analytics Cannabis testing lab has installed a LexaGene LX2 pathogen analyser beta unit at their Massachusetts facility
https://www.cleanroomtechnology.com/news/article_page/Cannabis_testing_lab_adopts_DNA-based_microbial_detection_technique/158889
You aren't kidding. TLRY is trading under $25 today. Just not good to get caught up in the hype.
It's essentially lost 50% of it value from the May highs. Very volatile stock.
As are most of them that just keep sinking like-
VATE, POTN, CANB, SIPC, HIPH, NBEV, TRTC, AMMJ, MJNA, AXIM, TLRY, CGC
I like Sleek's summary and he may be right. But if you got in high in the ones I listed you have lost your behind on paper bigtime.
Are they buys now. I wish I knew.
Fortuna announces the start of pre-production mining at the Lindero Project, Argentina
The Lindero Project construction remains on track with placement of Mineral Reserves on the leach pad scheduled for the fourth quarter of 2019 and first doré pour planned in the first quarter of 2020. With Lindero in its first year of full production, Fortuna's consolidated precious metals annual production1 is expected to increase in 2020 to between 7.5 and 8.3 million ounces of silver and between 189 to 209 thousand ounces of gold or between 293 to 324 thousand ounces of gold equivalent.
That means their revenue will almost double from $246M to $450M+.
You are talking about PURA right?
Can someone explain why there was such a huge sell off from June? Especially when things were going so well. Thx.
I made good money on the first big run up but now I don't trust a thing they say. No harvest and no details about 180. Total switcheroo. Then just silence. Now after 18yrs of development they suddenly have some deal with Hydrensis. You kidding me. I want details on what they did with the shrimp in 180 first.
Tripled the shs in a year and we're supposed to be ok with that. You kidding me. Virus in the last batch. You telling me they have no way to test before buying and starting to grow a new batch. You kidding me.
GHS getting shares at a penny to resell. You kidding me. Many loans coming due. Where's the money coming from to pay them? Too many unanswered questions for me. I don't blindly hope all is well and they will suddenly expand and have revenue and the stock will skyrocket. Maybe I'm wrong and too skeptical but I still don't trust them. Why, just look at their track record and the screwy way they communicate.....when they decide to. GLTA
Lot 180 that was never publicly harvested can't still be in the tank. Why hasn't the company disclosed what they did with those shrimp?
Just one analyst predicts a price and up it goes? Is that how it works?
"LexaGene Reports on Successful Results from Beta Testing in Human Clinical Diagnostics Laboratory"
More excellent news. This time on Human testing. Complete correlation with the test lab but with results in an hour instead of days. The lab is very impressed with the LX2. Especially that the LX2 could determine multiple pathogens, antibiotic resistance helping select the right medicine and the open access allowing the lab to use their own assays. Not needing a clinical bio technician and quick results will save time and reduce costs.
It sank to .046 recently. It was momentary but it did.
Why after 18yrs of perfecting the RAS system would they now be involving Hydrensis in shrimp growing?
If this doesn't hit you between the eyes what will. I'd love to hear someone corroborate this statement. Anyone else close by that can also visit the facility and verify? Are we being taken for a ride?
NEWS: #LexaGene signs second cannabis testing lab ProVerde as a beta site.
https://finance.yahoo.com/news/lexagene-announces-second-hemp-cannabis-115800750.html
China is the largest shrimp importer in the world. They should buy SHMP.
"During the first week of testing LexaGene’s analyzer, all of the marijuana buds we processed had successful PCR, proving to us that LexaGene is exceptional in its ability to mitigate impacts from the cannabis matrix. We are very impressed with the underlying science behind the way the LexaGene technology performs its analysis and believe it will be a game changer for the industry.”
https://finance.yahoo.com/news/lexagene-reports-beta-results-cannabis-144732941.html
I compare SHMP to Beyond Meat (BYND) which is a new revolutionary food source. In my opinion so is SHMP a new revolutionary food source. BYND is currently selling for $150/sh with 60M shs out(BYND has been as high as $239/sh). Comparing at $150/sh that would put SHMP with 323M shs out at $28/sh.
This time could run much higher than last time.
News leaking.
They appear to be going bk.
Good point.
"During the first week of testing LexaGene’s analyzer, all of the marijuana buds we processed had successful PCR, proving to us that LexaGene is exceptional in its ability to mitigate impacts from the cannabis matrix. We are very impressed with the underlying science behind the way the LexaGene technology performs its analysis and believe it will be a game changer for the industry.”
https://finance.yahoo.com/news/lexagene-reports-beta-results-cannabis-144732941.html
Have to ask why they never sold one shrimp in that first batch they promised to harvest in front of Press cameras but decided not to at the last minute.
Your figures look very accurate. Shares tripled to 323M in a year. At that rate they will have 900M shares out in another year just to keep the doors open.
Any idea why they thought it was their only option to accept that kind of financing? Seems desperate. Would think they could have at least gotten 5c deals.
A penny a share!! That's crazy. How many of those deals did they do?
Appears there are some convertible notes coming up:
On January 16, 2019, the Company entered into an 10% convertible promissory note for $205,436, with an OID of $18,686, for a purchase price of $186,750, which matures on October 16, 2019.
On February 4, 2019, the Company entered into an 10% convertible promissory note for $85.500, with an OID of $7,500, for a purchase price of $75,000, which matures on November 4, 2019.
On March 1, 2019, the Company entered into an 10% convertible promissory note for $168,000, with an OID of $18,000, for a purchase price of $150,000, which matures on November 1, 2019.
On April 17, 2019, the Company entered into an 10% convertible promissory note for $110,000, with an OID of $10,000, for a purchase price of $100,000, which matures on January 23, 2020
Nothing was ever sold and no harvest results were ever published that I saw. They waited right up to the harvest date almost and then decided to pull the plug. Not a good decision in my book. I do like their tech but I expect them to keep it transparent and publish results.
The company as well as Peter lied to us about holding a public harvest with reporters and cameras present. They never said why they didn't hold that meeting or publish the harvest report. That deception and the fact they have tripled the shares outstanding in about a year has made me cautious.
I do however wish I'd bought some when it went under 5c recently. This new financing adds a lot of shares. They can sell up to 900 Million shs. At this rate they might get there.
Low float, more cash than debt, new exploration happening and silver prices are zooming up. EXK is my silver stock of choice. BUY
TooFrank, I watched the whole video. Shrimp farming currently is disgusting, dangerous and harmful to your health and the environment.
Huge corporations are getting rich and ruining the world we live in.
The technology Natural Shrimp provides will hopefully eventually take over from these criminals who should all be in jail.
They do have only $137k cash and $4M in debt. They need sales. Lots of sales.
What happened to the new tanks and systems they ordered?
Share dilution continues at a rapid pace. Outstanding shs at 300M+ are 3X outstanding just a year ago.
https://finance.yahoo.com/news/lexagene-place-beta-unit-human-115800074.html
Excellent news from LexaGene
Food and water safety are top priority. LexaGene is the solution.
The LX2 has so many applications.